Clearmind’s Mark Haden Discusses the Incredible Potential of MEAI as treatment for Alcoholism

Health and addiction problems plague the modern world and Clearmind is looking to improve the landscape. With new, cutting-edge, psychedelic-based medicine, Clearmind is developing the perfect solution to a variety of afflictions. With a focus on alcohol abuse and binge drinking, and with a world-class team of scientists heading the project, Clearmind is making waves in the pharmaceutical industry. Jim Gordon from Small Cap Power interviews Clearmind’s VP of Business Development Mark Haden for more specifics!

To read our full disclosure, please click on the button below: